PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany.\', \'DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.\', \'Walther Straub Institute for Pharmacology and Toxicology, Ludwig-Maximilians-Universität, Munich, Germany.\', \'Interdisciplinary Center for Clinical Research (IZKF), Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.\', \'Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.\', \'Divison of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Switzerland.\', \'Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.\', \'Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1055/s-0040-1718735
?:hasPublicationType
?:journal
  • Thrombosis and haemostasis
is ?:pmid of
?:pmid
?:pmid
  • 33124029
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.074
?:rankingScore_hIndex
  • 176
is ?:relation_isRelatedTo_publication of
?:title
  • Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all